APA (7th ed.) Citation

Taylor, P. C., Kadakia, A., Milligan, J., Romero, A., Howell, O., Patel, P. A., . . . Caporali, R. (2026). Comparative Effectiveness of Upadacitinib vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting. Rheumatology & Therapy, 13(3), 799. https://doi.org/10.1007/s40744-026-00855-0

Chicago Style (17th ed.) Citation

Taylor, Peter C., Aditi Kadakia, Jack Milligan, Ana Romero, Oliver Howell, Pankaj A. Patel, Sophie Barlow, and Roberto Caporali. "Comparative Effectiveness of Upadacitinib Vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting." Rheumatology & Therapy 13, no. 3 (2026): 799. https://doi.org/10.1007/s40744-026-00855-0.

MLA (9th ed.) Citation

Taylor, Peter C., et al. "Comparative Effectiveness of Upadacitinib Vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting." Rheumatology & Therapy, vol. 13, no. 3, 2026, p. 799, https://doi.org/10.1007/s40744-026-00855-0.